ST. LOUIS , Nov. 12, 2024 /PRNewswire/ -- Radialogica LLC and Scientific RT GmbH announced clinical availability of the latest version of SciMoCa, the premier Monte Carlo -based solution for secondary dose computation and plan quality assurance.
SciMoCa version 1.8 includes support for the Elekta Unity MR-Linac as well as performance enhancements to facilitate real-time adaptive workflows. SciMoCa is the first clinically available patient QA tool that provides independent, Monte Carlo -based dose calculations for the Unity treatment machine.
Monte Carlo dose computation is essential for irradiation in a magnetic field but time constraints have limited its utility for online treatment adaptation. Following successful pre-clinical validation at the IRCCS Sacro Cuore-Don Calabria Cancer Care Center, the accuracy and precision of Monte Carlo is now available to the Elekta Unity user community. The latest version of SciMoCa also includes performance improvements and workflow enhancements that respond to the clinical constraints associated with online adaptive applications.
SciMoCa's real-time capability will enable Monte Carlo -based dose calculation and treatment plan verification within the online adaptive setting for Elekta Unity and Varian Ethos users. "Patient-specific QA for real-time plan adaptation requires a maximum of accuracy due to time constraints on one hand and the unforgiving nature of hypofractionation on the other. With Monte Carlo , we have the only method that .
